Balchem has defined a new five-year growth strategy on the heels of its acquisition of Kappa Bioscience and Bergstrom Nutrition, which added K2Vital and OptiMSM to its portfolio. Frederic Boned, senior vice president-general manager at Balchem, reveals how the company is “unlocking new potential” by cross-selling branded ingredients, bringing more awareness to the market and expanding internationally.
Upcoming webinars

Texture challenges in high protein bars: Understanding the benefits of casein
Lactalis Ingredients
Register now

Top Nutrition Trends 2027
Nutrition Insight
Register now

Pure love deserves a pure start: Solutions that give the best start from day one
dsm-firmenich
Register now
All upcoming webinars
Subscribe to our newsletters
By continuing to browse our site you agree to our Privacy Statement

















